What Kyntra Bio, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 3 |
| Sells | 0 | 0 |
| Total trades | 2 | 11 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 6,500 |
| Disposed | 231 | 1,129 |
| Net activity | −231 | +5,371 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| DeLucia David | Chief Financial Officer | Sep 06 | Withheld — tax / exercise cost · F | −22 | $8.55 | −$188 | 4,355 |
| Wettig Thane | CEO | Sep 06 | Withheld — tax / exercise cost · F | −209 | $8.55 | −$1.79K | 26,796 |
| Wettig Thane | CEO | Jun 06 | Withheld — tax / exercise cost · F | −198 | $6.71 | −$1.33K | 27,005 |
| DeLucia David | Chief Financial Officer | Jun 06 | Withheld — tax / exercise cost · F | −52 | $6.71 | −$349 | 4,377 |
| Wettig Thane | CEO | May 14 | Open-market buy · P | +2,800 | $7.09 | +$19.9K | 27,203 |
| Wettig Thane | CEO | Mar 06 | Withheld — tax / exercise cost · F | −277 | $6.84 | −$1.89K | 24,403 |
| DeLucia David | Chief Financial Officer | Mar 06 | Withheld — tax / exercise cost · F | −60 | $6.84 | −$410 | 4,429 |
| Wettig Thane | CEO | Dec 06 | Withheld — tax / exercise cost · F | −259 | $8.42 | −$2.18K | 24,680 |
| DeLucia David | Chief Financial Officer | Dec 06 | Withheld — tax / exercise cost · F | −52 | $8.42 | −$438 | 4,489 |
| Wettig Thane | CEO | Nov 17 | Open-market buy · P | +2,700 | $9.10 | +$24.6K | 24,939 |
| Wettig Thane | CEO | Nov 13 | Open-market buy · P | +1,000 | $9.18 | +$9.18K | 22,239 |
| DeLucia David | Chief Financial Officer | Sep 06 | Withheld — tax / exercise cost · F | −53 | $12.10 | −$641 | 4,541 |
| Wettig Thane | CEO | Sep 06 | Withheld — tax / exercise cost · F | −248 | $12.10 | −$3K | 21,239 |
| Schoeneck James A | Director | Jun 30 | Open-market buy · P | +23,567 | $5.07 | +$119K | 39,666 |
| DeLucia David | Chief Financial Officer | Jun 06 | Withheld — tax / exercise cost · F | −51 | $7.83 | −$399 | 4,594 |
| Wettig Thane | CEO | Jun 06 | Withheld — tax / exercise cost · F | −246 | $7.83 | −$1.93K | 21,487 |
| Wettig Thane | CEO | Mar 24 | Open-market buy · P | +145,000 | $0.35 | +$50.7K | 543,329 |
| Schoeneck James A | Director | Mar 21 | Open-market buy · P | +50,000 | $0.34 | +$17K | 373,722 |
| Schoeneck James A | Director | Mar 20 | Open-market buy · P | +250,000 | $0.35 | +$88K | 323,722 |
| Wettig Thane | CEO | Mar 06 | Withheld — tax / exercise cost · F | −367 | $0.39 | −$143 | 398,329 |
Loading...
